Moors & Cabot, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Moors & Cabot, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$1.41 - $2.5 $16,003 - $28,375	11,350 New	11,350 $17,000
Q2 2022 Aug 08, 2022	SELL	$1.44 - $3.98 $15,624 - $43,183	-10,850 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $1,485 - $2,600	-500 Reduced 4.41%	10,850 $39,000
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $21,457 - $32,078	-4,300 Reduced 27.48%	11,350 $57,000
Q3 2021 Dec 08, 2021	BUY	$7.16 - $9.69 $112,054 - $151,648	15,650 New	15,650 $113,000
Q3 2021 Nov 05, 2021	SELL	$7.16 - $9.69 $115,634 - $156,493	-16,150 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$6.23 - $10.03 $15,263 - $24,573	2,450 Added 17.88%	16,150 $150,000
Q1 2021 May 12, 2021	BUY	$8.81 - $16.96 $120,697 - $232,352	13,700 New	13,700 $127,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.